Literature DB >> 15188023

Immunophenotyping of tumor-infiltrating mononuclear cells in ovarian carcinoma.

Thanaa el-A Helal1, Ali E Khalf Alla, Mohamed A Laban, Remon M Fahmy.   

Abstract

Infiltrating mononuclear cells play an important role in many types of cancer. The aim of this work was to determine the immunologic characteristics of mononuclear cellular infiltrate in ovarian cancer as compared to benign ovarian tumors. Paraffin-embedded tissues obtained from 52 ovarian carcinomas and 21 benign ovarian neoplasms were examined immunohistochemically to demonstrate suppressor/cytotoxic T cells and macrophages by using CD8 and CD68 monoclonal antibodies, respectively. The mean percentage of CD8+ cells was much higher in the malignant than in the benign group (P=0.00009). Similarly, the mean level of CD68+ cells was significantly higher in carcinomas than in benign cases (P=0.006). There was a significant negative correlation between the percentage of CD8+ cells and CD68+ cells in the malignant group (P=0.000002). Conversely, no correlation could be obtained between the values of these two cell types in the benign lesions. In the malignant group, although the percentages of CD8+ cells and CD68+ cells were not related to tumor differentiation, they were significantly related to tumor type. CD8+ cells were significantly higher in the serous (P=0.02), and CD68+ cells were higher in the mucinous carcinomas (P=0.0005). CD8+ T cells and macrophages constitute a major component of the infiltrating mononuclear cells in ovarian carcinoma. Their frequency seems to be related to the tumor type rather than the degree of tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188023     DOI: 10.1007/BF02893460

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   2.874


  19 in total

1.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

Authors:  R P Negus; G W Stamp; J Hadley; F R Balkwill
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

Review 3.  The host-tumor immune conflict: from immunosuppression to resistance and destruction.

Authors:  S Chouaib; C Asselin-Paturel; F Mami-Chouaib; A Caignard; J Y Blay
Journal:  Immunol Today       Date:  1997-10

4.  Cell-mediated immunity in patients with ovarian carcinoma.

Authors:  S Y Chen; D Koffler; C J Cohen
Journal:  Am J Obstet Gynecol       Date:  1973-02-15       Impact factor: 8.661

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.

Authors:  D C Lockhart; A K Chan; S Mak; H G Joo; H A Daust; A Carritte; C C Douville; P S Goedegebuure; T J Eberlein
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

7.  Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells.

Authors:  Luca Puccetti; Roberto Manetti; Paola Parronchi; Marie-Pierre Piccinni; Carmelo Mavilia; Marcc Carini; Sergio Romagnani; Enrico Maggi
Journal:  Int J Cancer       Date:  2002-04-10       Impact factor: 7.396

8.  Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas--correlation with tumour differentiation.

Authors:  A Naukkarinen; K J Syrjänen
Journal:  J Pathol       Date:  1990-03       Impact factor: 7.996

Review 9.  Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes.

Authors:  R S Freedman; C D Platsoucas
Journal:  Cancer Treat Res       Date:  1996

10.  Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; A K Bhan
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

View more
  3 in total

1.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

2.  Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy.

Authors:  Hans Bösmüller; Sophie Haitchi-Petnehazy; Gerald Webersinke; Renate Marschon; Franz Roithmeier; Wolfgang Stummvoll; Tanja Fehm; Margit Klier-Richter; Irina Bonzheim; Annette Staebler; Falko Fend
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

3.  Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.

Authors:  Katy Milne; Rebecca O Barnes; Adam Girardin; Melanie A Mawer; Nancy J Nesslinger; Alvin Ng; Julie S Nielsen; Robert Sahota; Eric Tran; John R Webb; May Q Wong; Darin A Wick; Andrew Wray; Elissa McMurtrie; Martin Köbel; Steven E Kalloger; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.